The expression of PAFAH1B3 was increased in HCC tumor tissue [18], and the effectiveness of treatment is enhanced by PAFAH1B3 blockade, which reduces the proliferation of HCC tumor cells [12, 19]. This evidence concerns the gene PAFAH1B3 and neoplasm.